Marksans Pharma up 3% as arm secures marketing authorisation for Baclofen

Quick Summary:

Marksans Pharma’s operating revenue stood at Rs 681.8 crore, up 16.

The gross profit stood at Rs 383.5 crore, up 22.4 per cent Y-o-Y, with a gross margin expansion of 279 basis points (bps) Y-o-Y to 56.2 per cent.

Marksans Pharma share’s 52-week high is Rs 358.50, while its 52-week low is Rs 130.15 apiece.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: IndiaAustralia

Topics: Marksans Pharma stock levels BSE Marksans Pharma Stock Price Marksans Pharma Shares levels Buzzing Stock Marksans Pharma share price today Marksans Pharma NSE Marksans Pharma stock price today Marksans Pharma share price Marksans Pharma share levels

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-03-19 @ 13:11:21 (10 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 423 words

Reading Time: 3 minutes read

Sentences: 21 lines

Sentence Length: 21 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 27167967

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 287 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions